Hong Kong Pharmaceuticals Stock News

Chongqing Rural Commercial Bank (SEHK:3618) has drawn fresh attention after reporting full year 2025 earnings and proposing an ordinary final cash dividend, giving investors new information on profitability and shareholder payouts. See our latest analysis for Chongqing Rural Commercial Bank. The share price has reacted firmly to these announcements, with a 1-day share price return of 1.58%, a 30-day share price return of 17.50% and a 1-year total shareholder return of 35.94%, building on a...

Shenzhen International Holdings (SEHK:152) has drawn attention after reporting full year 2025 results with higher sales but lower net income and earnings per share, as well as fresh progress in its South China Logistics Park transformation. See our latest analysis for Shenzhen International Holdings. At a share price of HK$7.16, Shenzhen International Holdings has seen a 30 day share price return decline of 18.64% and a year to date share price return decline of 16.84%. The 3 year total...

Recent performance snapshot Kingsoft (SEHK:3888) has been under pressure, with the share price showing a 2.6% decline over the past day and deeper negative returns over the week, month, past 3 months, and past year. In contrast to that weaker share performance, the business currently reports HK$9,682.881m in revenue and HK$2,004.388m in net income, with annual revenue growth of 11.66% and annual net income growth of 1.66%. See our latest analysis for Kingsoft. The current share price of...

Industrial and Commercial Bank of China (SEHK:1398) has drawn fresh investor attention after releasing its full year 2025 results and declaring a final ordinary cash dividend tied to that reporting period. See our latest analysis for Industrial and Commercial Bank of China. The latest dividend and earnings update has landed against a backdrop of a 9.8% year to date share price return and a 34.5% 1 year total shareholder return. The 3 year total shareholder return of 113.6% points to momentum...

Viewing insider transactions for China Gas Holdings Limited's ( HKG:384 ) over the last year, we see that insiders were...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Investors weren't pleased with the recent soft earnings report from Great Wall Motor Company Limited ( HKG:2333 ). We...

The subdued market reaction suggests that Changan Minsheng APLL Logistics Co., Ltd.'s ( HKG:1292 ) recent earnings...

Soft earnings didn't appear to concern Hang Lung Properties Limited's ( HKG:101 ) shareholders over the last week. We...

HBM Holdings (SEHK:2142) has drawn fresh investor attention after reporting full year 2025 earnings, with sales of US$157.98 million and net income of US$91.33 million, alongside clinical and licensing progress for HBM9378. See our latest analysis for HBM Holdings. The recent earnings release and clinical updates appear to have coincided with a strong 7 day share price return of 14.48% and a 30 day share price return of 23.89%, building on a 1 year total shareholder return of 91.66% and a...

Why Central New Energy Holding Group (SEHK:1735) just caught investors’ attention Central New Energy Holding Group (SEHK:1735) recently released full year 2025 results, reporting sales of HK$11,016.85 million and net income of HK$34.24 million, compared with HK$6,032.03 million and HK$106.39 million a year earlier. Basic and diluted earnings per share from continuing operations were HK$0.0081, compared with HK$0.0252 previously. This combination helps explain recent interest in how the stock...

Melco International Development’s earnings turnaround Melco International Development (SEHK:200) has moved back into the black, reporting full year 2025 net income of HK$1,058.31 million on sales of HK$40,240.89 million after a loss the previous year. See our latest analysis for Melco International Development. The earnings return has arrived alongside a 10.82% 7 day share price return and a 5.26% 30 day share price return. However, the 90 day share price return of a 2.33% decline and the 3...

Why China Youran Dairy Group’s latest circular delay and earnings matter for investors China Youran Dairy Group (SEHK:9858) has drawn attention after further delaying its circular on a connected share subscription and whitewash waiver, while also reporting full year 2025 results that included CNY 20,653.71 million in sales and a narrowed net loss. See our latest analysis for China Youran Dairy Group. At a share price of HK$4.21, the stock has a 1 day share price return of 5.78% and 7 day...

Earnings and dividend move put Ruifeng Power Group in focus Ruifeng Power Group (SEHK:2025) has drawn investor attention after reporting full year 2025 results together with a proposed increase in its final dividend, combining earnings information with a clearer signal on shareholder payouts. For the year ended 31 December 2025, Ruifeng Power Group reported sales of CN¥1,109.4 million and net income of CN¥23.27 million, with basic earnings per share from continuing operations of CN¥0.029. See...

Chery Automobile: Recent Price Moves Catch Investor Attention Chery Automobile (SEHK:9973) has drawn fresh attention after a recent share price move, with the stock showing positive returns over the past week, month, and past 3 months. See our latest analysis for Chery Automobile. The recent 1 day share price return of 15.26% at HK$32.02 caps a period of building momentum, with short term moves outpacing the 6.03% year to date share price return. This is shifting attention back to how the...

What GCL Technology Holdings' Latest Earnings Mean For Investors GCL Technology Holdings (SEHK:3800) released full year 2025 results, reporting sales of CN¥14,424.93 million compared with CN¥15,097.56 million a year earlier, and a narrowed net loss of CN¥2,867.89 million. See our latest analysis for GCL Technology Holdings. The latest results arrived after a period where the share price has been under pressure, with a 30 day share price return of an 11.32% decline and a 90 day share price...

Earnings turnaround puts Oshidori International Holdings (SEHK:622) in focus Oshidori International Holdings (SEHK:622) has caught investor attention after reporting full year 2025 earnings, shifting from a net loss to net income of HK$179.05 million with positive basic and diluted earnings per share. See our latest analysis for Oshidori International Holdings. At a share price of HK$1.73, Oshidori International Holdings has seen a 130.67% year to date share price return, while its 1 year...

China Resources Mixc Lifestyle Services (SEHK:1209) has drawn fresh attention after reporting full year 2025 results, with sales of CN¥18,021.62 million and net income of CN¥3,969.02 million from continuing operations. See our latest analysis for China Resources Mixc Lifestyle Services. The earnings release comes after a strong run, with a 7 day share price return of 5.54% and a year to date share price return of 8.78%. The 1 year total shareholder return of 40.12% points to momentum that has...

Why Luye Pharma’s latest earnings matter for investors Luye Pharma Group (SEHK:2186) has drawn fresh attention after reporting its full year 2025 results, with higher sales and net income alongside a decision not to declare a 2025 dividend. The company reported sales of CN¥6,308.37 million for 2025, compared with CN¥6,061.44 million a year earlier. Net income came in at CN¥618.75 million, up from CN¥471.89 million, while basic earnings per share from continuing operations were CN¥0.1588...

CGN Power (SEHK:1816) just reported full year 2025 results showing lower revenue and net income, alongside a proposed smaller final dividend of RMB 0.086 per share. This is putting income expectations and valuation under closer scrutiny for investors. See our latest analysis for CGN Power. The earnings and dividend announcement comes after a period of strong gains for investors, with a 30 day share price return of 12.46% and a 1 year total shareholder return of 43.16%. However, the 7 day...

Zhejiang Expressway (SEHK:576) has released new figures for its 2025 full year earnings, together with a proposed dividend increase. This combination gives income focused investors new information to assess. See our latest analysis for Zhejiang Expressway. At a share price of HK$7.45, Zhejiang Expressway has seen a 1 month share price return of 7.97%, while its 1 year total shareholder return of 21.27% and 3 year total shareholder return of 53.43% point to momentum that has built over time...

What the latest earnings and drug news mean for Hansoh Pharmaceutical Group The latest move in Hansoh Pharmaceutical Group (SEHK:3692) is being shaped by two fresh developments: full year 2025 earnings and new regulatory progress for its autoimmune drug XINYUE in China. For the year ended 31 December 2025, Hansoh Pharmaceutical Group reported sales of CN¥15,028.32 million, compared with CN¥12,260.81 million a year earlier, and net income of CN¥5,555.46 million versus CN¥4,371.83...

What the latest earnings and dividend move mean for Shougang Fushan Resources Group (SEHK:639) Shougang Fushan Resources Group (SEHK:639) has drawn attention after reporting full year 2025 results showing lower net income and earnings per share, alongside a proposed final dividend of HK$0.06 per share. This combination of reduced profitability and a smaller final payout raises straightforward questions for you as a shareholder, especially around income expectations, payout sustainability, and...

China Longyuan Power Group (SEHK:916) has released its full year 2025 results, reporting sales of CN¥30,252.71 million and net income of CN¥4,526.22 million, both lower than the previous year. See our latest analysis for China Longyuan Power Group. The stock has been under pressure in the past month, with an 8.69% 30 day share price return and a 9.04% 7 day share price return, although the 1 year total shareholder return of 14.31% contrasts with weaker 3 and 5 year total shareholder...